Mesothelioma patients may benefit from the results of the clinical trials being conducted at Memorial Sloan-Kettering Cancer Center in New York. Recently, researchers have tested a Wilms Tumor-1 (WT1) vaccine to see if it delays or prevents malignant pleural...
Clinical Trials Start for GL-ONC1 Drug That May Benefit Mesothelioma Patients
read more